Management strategies in antithrombotic therapy
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Kaituhi rangatōpū: | |
| Ētahi atu kaituhi: | |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Chichester ; Hoboken, N.J. :
John Wiley and Sons,
c2007.
|
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- Thrombosis and antithrombotics in vascular disease
- Aspirin
- Thienopyridines, ticlopidine, and clopidogrel
- Platelet glycoprotein IIb/IIIa inhibitors
- Unfractionated heparin
- Low-molecular-weight heparins
- Direct thrombin inhibitors
- Fibrinolytic agents
- Acute ST-segment elevation myocardial infarction
- Acute coronary syndromes / non-ST-segment elevation myocardial infarction
- Anticoagulation strategies for patients undergoing percutaneous coronary intervention
- Venous thromboembolic disease
- Heparin-induced thrombocytopenia.